Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Sigurd Berven

Orthopaedic Surgery San Francisco, CA Medical Doctor

NPI 1336193812 CMS profile 105603

400 Parnassus Ave, 3Rd Floor, San Francisco, CA 94143

Open in the dashboard

General payments

$4,073,660

667 records reported · program years 2019–2025

Research payments

$9,750

Paid to them · 9 records reported · program years 2019–2025

Ownership & investment interest

$1,804,880

4 holdings reported · through program year 2025

Through program year 2025, Sigurd Berven of San Francisco, CA is reported in the CMS Open Payments database as having received $4,073,660 across 667 general payments and $9,750 in research payments paid to them. They also declared ownership or investment interests valued at $1,804,880 across 4 holdings.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

13 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $407,319 89
2024 General $1,076,329 105
2023 General $935,036 135
2022 General $451,757 73
2021 General $375,792 116
2020 General $398,167 88
2020 Research $2,850 3
2019 General $429,261 61
2019 Research $6,900 6
2024 Ownership $1,692,380 1
2021 Ownership $37,500 1
2020 Ownership $37,500 1
2019 Ownership $37,500 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Sigurd Berven
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Sigurd Berven were reported at $407,319. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Sigurd Berven Orthopaedic Surgery median Middle half National median
2019 $429,261 $644 $140–$2,844 $163
2020 $398,167 $312 $75–$1,860 $114
2021 $375,792 $520 $117–$2,495 $132
2022 $451,757 $598 $128–$2,731 $149
2023 $935,036 $461 $128–$2,264 $160
2024 $1,076,329 $497 $134–$2,475 $164
2025 $407,319 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic, Inc. $2,232,090 188 payments
  2. Stryker Corporation $1,271,884 45 payments
  3. DePuy Synthes Products, Inc. $102,956 3 payments
  4. Globus Medical, Inc. $80,954 37 payments
  5. Medtronic USA, Inc. $66,071 61 payments
  6. Kyocera Medical Technologies, Inc. $52,956 6 payments
  7. Integrity Implants Inc $46,926 73 payments
  8. Carlsmed, Inc. $44,133 34 payments
  9. SI-BONE, Inc. $28,666 31 payments
  10. Spineology Inc. $25,428 26 payments
  11. Other $121,595 163 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Royalty or License $3,440,081 62 payments
  2. Consulting Fee $326,355 103 payments
  3. Acquisitions $102,956 3 payments
  4. Travel and Lodging $95,629 153 payments
  5. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $79,190 25 payments
  6. Food and Beverage $28,374 318 payments
  7. Gift $575 2 payments
  8. Entertainment $499 1 payment
Products named General payments · program years 2019–2025
  1. TRITANIUM Hips $661,769 9 payments
  2. TRITANIUM Hips $579,844 20 payments
  3. aprevo $41,850 28 payments
  4. INFUSE BONE GRAFT $29,118 20 payments
  5. OPTIMESH EXPANDABLE INTERBODY FUSION SYSTEM $25,253 25 payments
  6. IFUSE IMPLANT SYSTEM $24,250 5 payments
  7. Toro $22,549 25 payments
  8. EVEREST SPINAL SYSTEM $20,336 2 payments
  9. XIA 3 $20,250 1 payment
  10. OASYS $20,250 1 payment
  11. Other $307,124 346 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Zimmer Biomet Holdings, Inc. $9,750 9 payments

Billing to Medicare

Part B · data year 2024 · 49 billing codes

Paid by Medicare

$208,556

Medicare's payments for the services billed

Medicare patients

102

Average age 73

Services billed

510

59 women, 43 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 73%
Osteoporosis 36%
Depression 34%
Diabetes 23%
Ischemic heart disease 22%
COPD 21%
Chronic kidney disease 20%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

676 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record